ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,261.80
0.50%
S&P ASX All Technology
3,859.50
0.90%
Brent Oil
73.44
0.00%
US Dollar vs AUD
1.60875
0.00%
Bitcoin
94,998.90
-0.15%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Biora Therapeutics Inc (BIOR)

  7. Biora Therapeutics Inc (BIOR) News

Biora Therapeutics Inc

Biora Therapeutics Inc (BIOR)

Biora Therapeutics Inc (PK)
0.5597
0.00
(0.00%)
Closed 29 December 8:00AM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

BIOR News

Official News Only

Form PRE 14A - Other preliminary proxy statements
Edgar (US Regulatory)
12 October 2024
BIOR (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
11 October 2024
BIOR (0.00%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
17 September 2024
BIOR (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
14 September 2024
BIOR (0.00%)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Edgar (US Regulatory)
14 September 2024
BIOR (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
05 September 2024
BIOR (0.00%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
04 September 2024
BIOR (0.00%)

Form PRE 14A - Other preliminary proxy statements
Edgar (US Regulatory)
04 September 2024
BIOR (0.00%)

Form S-3 - Registration statement under Securities Act of 1933
Edgar (US Regulatory)
24 August 2024
BIOR (0.00%)

BIOR Discussion

View Posts
Renee Renee 3 weeks ago
BIOR delisted from the Nasdaq to the OTC. ***stock dropped 60% from $1.35 to .55 on ~2 million volume

https://otce.finra.org/otce/dailyList?viewType=Additions
👍️0
SmellMyFinger SmellMyFinger 3 weeks ago
FYI, this should be delisted to OTC tomorrow.
👍️0
Monksdream Monksdream 2 months ago
BIOR, new 52 week low
👍️0
Monksdream Monksdream 2 months ago
BIOR, new 52 week low
👍️0
The Night Stalker The Night Stalker 7 months ago
nice
👍️0
Arnold25764 Arnold25764 8 months ago
Any possible catalyst here?
👍️0
Monksdream Monksdream 9 months ago
BIOR new 52 lo
👍️0
Monksdream Monksdream 9 months ago
BIOR new 52 lo
👍️0
Monksdream Monksdream 9 months ago
BIOR 10Q due 3/26
👍️0
Monksdream Monksdream 9 months ago
BIOR under $2
👍️0
glenn1919 glenn1919 10 months ago
BIOR.................................https://stockcharts.com/h-sc/ui?s=BIOR&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 10 months ago
BIOR..................................https://stockcharts.com/h-sc/ui?s=BIOR&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 1 year ago
BIOR new 52 week low
👍️0
Monksdream Monksdream 1 year ago
BOIR new 52 week low
👍️0
Monksdream Monksdream 1 year ago
BIOR new 52 week low
👍️0
TheFinalCD TheFinalCD 1 year ago
https://finviz.com/quote.ashx?t=BIOR&p=d

https://dilutiontracker.com/app/search/BIOR
👍️0
Awl416 Awl416 1 year ago
Biora Therapeutics Announces FDA Clearance of IND Application for Drug/Device Combination BT-600 Targeting Treatment of Ulcerative Colitis
👍️0
retireat40 retireat40 1 year ago
Looked good this morning at 2.66 but a crappy close.
👍️0
Monksdream Monksdream 1 year ago
BIOR Barchart Bottom 100
Biora Therapeutics Inc NASDAQ: BIOR



GoSymbol lookup
Health Care : Biotechnology | Small Cap ValueCompany profile
Biora Therapeutics, Inc. is a biotechnology company, which is focused on creating smart pills designed for targeted drug delivery to the gastrointestinal (GI) tract, and needle-free delivery of biotherapeutics. The Company's therapeutics pipeline includes two therapeutic delivery platforms: NAVICAP and BIOJET. NAVICAP is a targeted oral delivery platform of therapeutics to the site of disease in the GI tract, designed to improve outcomes for patients with inflammatory bowel disease (IBD). The NAVICAP drug delivery device is an investigational, clinical-stage, single-use ingestible device approximately the size of a fish oil capsule. BIOJET is a systemic oral delivery platform of biotherapeutics designed to replace injection with needle-free, oral delivery of molecules for better management of chronic diseases. The Company's targeted therapeutics pipeline programs include NAVICAP, BT-600 and BT-001. Its systemic therapeutics pipeline programs include BIOJET, BT-200 and BT-002.
👍️0

Your Recent History

NASDAQ
BIOR
Biora Therapeutics
EU
SGG1P
EURONEXT G SOC GEN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads